Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis

OBJECTIVE: Insulin glargine [300 U/mL (Gla-300)] achieved better glycemic control and reduced the risk of hypoglycemia in comparison to glargine [100 U/mL; (Gla-100)] in phase 3 trials. This is the first study to retrospectively evaluate the efficacy and safety of Gla-300 in Japanese type 1 and 2 di...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakanishi, Shuhei, Iwamoto, Masahiro, Kamei, Shinji, Hirukawa, Hidenori, Shimoda, Masashi, Tatsumi, Fuminori, Kohara, Kenji, Obata, Atsushi, Kimura, Tomohiko, Kinoshita, Tomoe, Irie, Shintaro, Sanada, Junpei, Fushimi, Yoshiro, Nishioka, Momoyo, Mizoguchi, Akiko, Kameyama, Miyuki, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995700/
https://www.ncbi.nlm.nih.gov/pubmed/29760318
http://dx.doi.org/10.2169/internalmedicine.9334-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995700/
https://www.ncbi.nlm.nih.gov/pubmed/29760318
http://dx.doi.org/10.2169/internalmedicine.9334-17

Ejemplares similares